Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Zhe, Shi, Lei, Wang, Yijin, Zhang, Jiyuan, Huang, Lei, Zhang, Chao, Liu, Shuhong, Zhao, Peng +10 more·2020·The Lancet Respiratory Medicine

Cited by (1,023)

Items 501–600 of 1,023

  1. Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT
    Chun Shuang Guan, Zhi Bin Lv, Shuo Yan, Yan Ni Du, Hui Chen, Lian Gui Wei, Ruming Xie, Bu Dong Chen · 2020 · Academic Radiology
  2. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
    Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, Mohd. Iqbal Yatoo, Ruchi Tiwari, Yashpal Singh Malik, Rajendra Pal Singh, Ranjit Sah, Ali Ahmed Rabaan, D. Katterine Bonilla‐Aldana et al. · 2020 · Travel Medicine and Infectious Disease
  3. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis
    Asma Fatima Boumaza, Laëtitia Gay, Soraya Mezouar, Eloïne Bestion, Aïssatou Bailo Diallo, Moïse Michel, Benoît Desnues, Didier Raoult, Bernard La Scola, Philippe Halfon et al. · 2021 · The Journal of Infectious Diseases
  4. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
    Byung‐Chul Lee, Insung Kang, Kyung–Rok Yu · 2021 · Journal of Clinical Medicine
  5. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
    Abdus Samad, Foysal Ahammad, Zulkar Nain, Rahat Alam, Raihan Rahman Imon, Mahadi Hasan, Md. Shahedur Rahman · 2020 · Journal of Biomolecular Structure and Dynamics
  6. Viral Respiratory Pathogens and Lung Injury
    Nicola Clementi, Sreya Ghosh, Maria De Santis, Matteo Castelli, Elena Criscuolo, Ivan Zanoni, Massimo Clementi, Nicasio Mancini · 2021 · Clinical Microbiology Reviews
  7. A single-cell transcriptomic landscape of the lungs of patients with COVID-19
    Si Wang, Xiaohong Yao, Shuai Ma, Yi‐Fang Ping, Yanling Fan, Shuhui Sun, Zhicheng He, Yu Shi, Liang Sun, Shiqi Xiao et al. · 2021 · Nature Cell Biology
  8. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis
    Tope Oyelade, Jaber Saud Alqahtani, Gabriele Canciani · 2020 · Tropical Medicine and Infectious Disease
  9. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
    Bingqing Xia, Xu-Rui Shen, Yang He, Xiaoyan Pan, Feng‐Liang Liu, Yi Wang, Feipu Yang, Sui Fang, Yan Ling Wu, Zilei Duan et al. · 2021 · Cell Research
  10. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?
    Lisette F. van Dam, Lucia J.M. Kroft, Lea Imeen van der Wal, Suzanne C. Cannegieter, Jeroen C.J. Eikenboom, Evert de Jonge, Menno Volkert Huisman, Frederikus Albertus Klok · 2020 · Thrombosis Research
  11. Current Policies and Measures on the Development of Traditional Chinese Medicine in China
    Wanying Wang, Hua Zhou, Yafeng Wang, Sang Bin-sheng, Liang Liu · 2020 · Pharmacological Research
  12. Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
    Katerina Pyrillou, Laura C. Burzynski, Murray C.H. Clarke · 2020 · Frontiers in Immunology
  13. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
    Ivana Lazarević, Vera Pravica, Danijela Miljanovic, Maja D. Cupic · 2021 · Viruses
  14. Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients
    Nathalie Lassau, Samy Ammari, Émilie Chouzenoux, Hugo Gortais, Paul Hérent, Matthieu Devilder, Samer Soliman, Olivier Meyrignac, Marie-Pauline Talabard, Jean-Philippe Lamarque et al. · 2021 · Nature Communications
  15. Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China
    Yin Wang, Weiwei Jiang, Qi He, Cheng Wang, Baoju Liu, Pan Zhou, Nianguo Dong, Qiaoxia Tong · 2020 · medRxiv
  16. Flexible Plasmonic Biosensors for Healthcare Monitoring: Progress and Prospects
    Song, Liping, Chen, Jing, Xu, Ben Bin, Huang, Youju · 2021 · ACS Nano
  17. An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
    Saurabh Kumar Sinha, Anshul Shakya, Satyendra Kuldip Prasad, Shashikant Singh, Nilambari S. Gurav, Rupali S. Prasad, Shailendra Shivaji Gurav · 2020 · Journal of Biomolecular Structure and Dynamics
  18. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
    Li Xiao, Hiroshi Sakagami, Nobuhiko Miwa · 2020 · Viruses
  19. T Cells: Warriors of SARS-CoV-2 Infection
    Paola de Candia, Francesco Prattichizzo, S. Garavelli, Giuseppe Matarese · 2020 · Trends in Immunology
  20. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
    Renuka Raman, Krishna J. Patel, Kishu Ranjan · 2021 · Biomolecules
  21. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
    Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, Sarah J Valk, Catherine Kimber, Elena Dorando, Ina Monsef, Erica M. Wood, Abigail Lamikanra, David J. Roberts et al. · 2021 · Cochrane Database of Systematic Reviews
  22. Can melatonin reduce the severity of COVID-19 pandemic?
    Alex Shneider, Aleksandr V. Kudriavtsev, Anna Vakhrusheva · 2020 · International Reviews of Immunology
  23. Extrapulmonary complications of COVID‐19: A multisystem disease?
    Kenneth I. Zheng, Gong Feng, Wen‐Yue Liu, Giovanni Targher, Christopher D. Byrne, Ming‐Hua Zheng · 2020 · Journal of Medical Virology
  24. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge
    Sambit Kumar Mohanty, Abhishek Satapathy, Machita M. Naidu, Sanjay Mukhopadhyay, Shivani Sharma, Lisa M. Barton, Edana Stroberg, Eric J. Duval, Dinesh Pradhan, Alexandar Tzankov et al. · 2020 · Diagnostic Pathology
  25. Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage
    Yanmei Chen, Yuanting Zheng, Ying Yu, Yunzhi Wang, Qingxia Huang, Feng Qian, Lei Sun, Zhigang Song, Ziyin Chen, Jinwen Feng et al. · 2020 · The EMBO Journal
  26. Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review
    Tadele Girum, Kifle Lentiro, Mulugeta Geremew, Biru Migora, Sisay Shewamare · 2020 · Tropical Medicine and Health
  27. Essential Fatty Acids and Their Metabolites in the Pathobiology of Inflammation and Its Resolution
    Undurti Narasimha Das · 2021 · Biomolecules
  28. Saúde mental dos profissionais de saúde no Brasil no contexto da pandemia por Covid-19
    Eder Samuel Oliveira Dantas · 2020 · Interface - Comunicação Saúde Educação
  29. A prospective clinical study of detailed neurological manifestations in patients with COVID-19
    Ömer Karadaş, Bilgin Öztürk, Ali Rıza Sonkaya · 2020 · Neurological Sciences
  30. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review
    Sarah J Valk, Vanessa Piechotta, Khai Li Chai, Carolyn J. Doree, Ina Monsef, Erica M. Wood, Abigail Lamikanra, Catherine Kimber, Zoe McQuilten, Cynthia So‐Osman et al. · 2020 · Cochrane Database of Systematic Reviews
  31. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza
    Lida P. Hariri, Crystal M. North, Angela R. Shih, Rebecca A. Israel, Jason H. Maley, Julian A. Villalba, Vladimir Vinarsky, Jonah N. Rubin, Daniel A. Okin, Alyssa Sclafani et al. · 2020 · CHEST Journal
  32. Controlling Cytokine Storm Is Vital in COVID-19
    Lu Tang, Zhinan Yin, Yu Hu, Heng Mei · 2020 · Frontiers in Immunology
  33. Hematological findings in coronavirus disease 2019: indications of progression of disease
    Xiaoqing Liu, Run Zhang, Guangsheng He · 2020 · Annals of Hematology
  34. SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
    Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, Nell Saunders, Rémy Robinot, Ludivine Grzelak, Delphine Planas, Jérémy Dufloo, Stacy Gellenoncourt, Alice Bongers et al. · 2021 · The EMBO Journal
  35. Combating COVID-19 with integrated traditional Chinese and Western medicine in China
    Liqiang Ni, Lili Chen, Xia Huang, Chouping Han, Jianrong Xu, Hong Zhang, Xin Luan, Yongfang Zhao, Jian‐Guang Xu, Wei-An Yuan et al. · 2020 · Acta Pharmaceutica Sinica B
  36. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2
    Robert Walter Körner, Mohamed Majjouti, Miguel Angel Alejandre Alcazar, Esther Mahabir · 2020 · Viruses
  37. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
    Guillaume Carissimo, Weili Xu, Immanuel Kwok, Mohammad Yazid Abdad, Yi‐Hao Chan, Siew‐Wai Fong, Kia Joo Puan, Cheryl Yi‐Pin Lee, Nicholas Kim‐Wah Yeo, Siti Naqiah Amrun et al. · 2020 · Nature Communications
  38. Environment and COVID-19: Pollutants, impacts, dissemination, management and recommendations for facing future epidemic threats
    Winfred Espejo, José E. Celis, Gustavo Chiang, Paulina Bahamonde · 2020 · The Science of The Total Environment
  39. Histopathological observations in COVID-19: a systematic review
    Vishwajit Ravavindra Deshmukh, Rohini Motwani, Ashutosh Kumar, Chiman Kumari, Khursheed Raza · 2020 · Journal of Clinical Pathology
  40. Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR
    Myungsun Park, Joungha Won, Byung Yoon Choi, Changjoon Justin Lee · 2020 · Experimental & Molecular Medicine
  41. Expression of Concern: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
    Armin Sadeghi, Safa Tahmasebi, Arshad Mahmood, Maria S. Kuznetsova, Hamed Valizadeh, Ali Taghizadieh, Masoud Nazemiyeh, Leili Aghebati Maleki, Farhad Jadidi‐Niaragh, Sanaz Abbaspour‐Aghdam et al. · 2020 · Journal of Cellular Physiology
  42. Azithromycin in viral infections
    Madeleine Oliver, Timothy Hinks · 2020 · Reviews in Medical Virology
  43. Hydrogen, a Novel Therapeutic Molecule, Regulates Oxidative Stress, Inflammation, and Apoptosis
    Yan Tian, Yafang Zhang, Yu Chen Wang, Yunxi Chen, Weiping Fan, Jianjun Zhou, Jing Qiao, Youzhen Wei · 2021 · Frontiers in Physiology
  44. Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor.
    Ali Rismanbaf, Sara Zarei · 2020 · Archives of Academic Emergency Medicine
  45. National Institute for the Infectious Diseases “L. Spallanzani” IRCCS. Recommendations for COVID-19 Clinical Management
    Emanuele Nicastri, Nicola Petrosillo, Tommaso Ascoli Bartoli, Luciana Lepore, Annalisa Mondi, Fabrizio Palmieri, Gianpiero D’Offizi, Luisa Marchioni, Silvia Murachelli, Giuseppe Ippolito et al. · 2020 · Infectious Disease Reports
  46. Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
    Yingxin Zhang, Jie Ding, Shaoda Ren, Weihua Wang, Yapei Yang, Shuangjing Li, Min Meng, Tiejun Wu, Daliang Liu, Suochen Tian et al. · 2020 · Stem Cell Research & Therapy
  47. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists
    Huijuan Jin, Candong Hong, Shengcai Chen, Yifan Zhou, Yong Wang, Ling Mao, Yanan Li, Quanwei He, Man Li, Ying Su et al. · 2020 · Stroke and Vascular Neurology
  48. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID‐19
    Jia Song, Ming Zeng, Hai Wang, Chuan Qin, Hongyan Hou, Ziyong Sun, San‐Peng Xu, Guoping Wang, Cuilian Guo, Yi‐Ke Deng et al. · 2020 · Allergy
  49. Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019
    Yanli Liu, Wenwu Sun, Jia Li, Liangkai Chen, Yujun Wang, Lijuan Zhang, Yu Li · 2020 · medRxiv
  50. SARS-CoV-2, ACE2 expression, and systemic organ invasion
    Usman Ashraf, Ahmed A. Abokor, Jonnelle M. Edwards, Emily W. Waigi, Rachel Royfman, Syed Abdul‐Moiz Hasan, Kathryn Smedlund, Ana Maria Trindade Grégio, Ritu Chakravarti, Lauren G. Koch · 2020 · Physiological Genomics
  51. Deep Learning System for COVID-19 Diagnosis Aid Using X-ray Pulmonary Images
    Javier Civit-Masot, Francisco Luna-Perejón, Manuel Domínguez-Morales, Anton Civit · 2020 · Applied Sciences
  52. Natural Killer Cell Dysfunction and Its Role in COVID-19
    Charmaine van Eeden, Lamia Khan, Mohammed S. Osman, Jan Willem Cohen Tervaert · 2020 · International Journal of Molecular Sciences
  53. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
    Hasan Satış, Hasan Selçuk Özger, Pınar Aysert Yıldız, Kenan Hızel, Özlem Gülbahar, Gonca Erbaş, Gülbin Aygencel, Özlem Güzel Tunçcan, Mehmet Akif Öztürk, Murat Dizbay et al. · 2020 · Cytokine
  54. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
    Ryan J. Farr, Christina L. Rootes, Louise C. Rowntree, Thi H. O. Nguyen, Luca Hensen, Łukasz Kedzierski, Allen C. Cheng, Katherine Kedzierska, Gough G. Au, Glenn A. Marsh et al. · 2021 · PLoS Pathogens
  55. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
    Olga A. Sukocheva, Rebekah Maksoud, Narasimha Murthy Beeraka, SubbaRao V. Madhunapantula, Mikhail Y. Sinelnikov, Vladimir Nikolaevich Nikolenko, Неганова Маргарита Евгеньевна, Sergey G. Klochkov, Mohammad Amjad Kamal, Donald Staines et al. · 2021 · Journal of Advanced Research
  56. Changes of hematological and immunological parameters in COVID-19 patients
    Xiaohong Yuan, Wanling Huang, Bing Ye, Cunrong Chen, Rongfeng Huang, Feng Wu, Wei Qin, Wei Zhang, Jianda Hu · 2020 · International Journal of Hematology
  57. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
    David L. Sulzer, Angelo Antonini, Valentina Leta, Anna Starikovsky Nordvig, Richard Jay Smeyne, James E. Goldman, Osama Al‐Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco et al. · 2020 · npj Parkinson s Disease
  58. The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19
    Giuseppe Cerullo, Massimo Negro, Mauro Parimbelli, Michela Pecoraro, Simone Perna, Giorgio Liguori, Mariangela Rondanelli, Hellas Cena, Giuseppe D’Antona · 2020 · Frontiers in Immunology
  59. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
    Miquéias Lopes‐Pacheco, Pedro Leme Silva, Fernanda Ferreira Cruz, Denise Battaglini, Chiara Robba, Paolo P. Pelosi, Marcelo Marcos Morales, Celso Caruso Neves, Patrícia R. M. Rocco · 2021 · Frontiers in Physiology
  60. ACE2-independent infection of T lymphocytes by SARS-CoV-2
    Xu-Rui Shen, Rong Geng, Qian Li, Ying Chen, Shufen Li, Qi Ming Wang, Juan Min, Yong Ping Yang, Bei Li, Ren-Di Jiang et al. · 2022 · Signal Transduction and Targeted Therapy
  61. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?
    Sherief Musa · 2020 · Arab Journal of Gastroenterology
  62. Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work
    Giovanni Messina, Rita Polito, Vincenzo Monda, Luigi Cipolloni, Nunzio R. Di Nunno, Giulio Di Mizio, Paolo Murabito, Marco Carotenuto, Antonietta Messina, Daniela Pisanelli et al. · 2020 · International Journal of Molecular Sciences
  63. Modeling the viral dynamics of SARS-CoV-2 infection
    Sunpeng Wang, Yang Pan, Quanyi Wang, Hongyu Miao, Ashley N. Brown, Libin Rong · 2020 · Mathematical Biosciences
  64. Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology
    Simon J. Cleary, Simon C. Pitchford, Richard Thomas Amison, Robert Carrington, C. Lorena Robaina Cabrera, Mélia Magnen, Mark R. Looney, Elaine Gray, Clive Peter Page · 2020 · British Journal of Pharmacology
  65. Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea
    Jeong‐Min Kim, Heui Man Kim, Eun Jung Lee, Hye Jun Jo, Young-Sil Yoon, Nam‐Joo Lee, Junseock Son, Yeji Lee, Mi Seon Kim, Yong-Pyo Lee et al. · 2020 · Osong Public Health and Research Perspectives
  66. Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
    Milena Sokołowska, Zuzanna Małgorzata Łukasik, Ioana Octavia Agache, Cezmi A. Akdiş, Deniz Akdiş, Mübeccel Akdiş, Weronika Barcik, Helen Annaruth Brough, Thomas Eiwegger, Andrzej Eljaszewicz et al. · 2020 · Allergy
  67. Animal and translational models of SARS-CoV-2 infection and COVID-19
    Matt D. Johansen, Aaron Trent Irving, Xavier Montagutelli, Michelle D. Tate, Ina Rudloff, Marcel F. Nold, Nicole G. Hansbro, Richard Kim, Chantal Donovan, Gang Liu et al. · 2020 · Mucosal Immunology
  68. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
    Grigoris Gerotziafas, M. Catalano, Mary Paula Colgan, Zsolt Pécsvárady, Jean Claude Wautrecht, Bahare Fazeli, Dan-Mircea Olinic, Katalin Farkas, Ismaı̈l Elalamy, Anna Falanga et al. · 2020 · Thrombosis and Haemostasis
  69. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
    Amene Saghazadeh, Nima Rezaei · 2020 · International Immunopharmacology
  70. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples
    Ling Leng, Ruiyuan Cao, Jie Ma, Danlei Mou, Yunping Zhu, Wei Li, Luye Lv, Dunqin Gao, Shikun Zhang, Feng Gong et al. · 2020 · Signal Transduction and Targeted Therapy
  71. Neutrophil elastase: From mechanisms to therapeutic potential
    Weilin Zeng, Yingqiu Song, Runze Wang, Rong He, Tianlu Wang · 2023 · Journal of Pharmaceutical Analysis
  72. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan
    Qian Fan, Wei Zhang, Bo Li, Dejia Li, Jian Zhang, Fang Zhao · 2020 · Frontiers in Cellular and Infection Microbiology
  73. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
    Rajesh Kumar Thimmulappa, Kiran Kumar Mudnakudu-Nagaraju, Chandan Shivamallu, Kuttinchantran Subramaniam, Arun Radhakrishnan, Suresh Bhojraj, Gowthamarajan Kuppusamy · 2021 · Heliyon
  74. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
    Junli Fan, Hui Wang, Guangming Ye, Xiaoling Cao, Xianqun Xu, Wenbin Tan, Yongxi Zhang · 2020 · Metabolism
  75. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19
    Terry Cheuk‐Fung Yip, Grace Chung-Yan Lui, Vincent Wai‐Sun Wong, Viola Chi‐Ying Chow, Tracy Hang-Yee Ho, Timothy Chun-Man Li, Y K Tse, David Shu-Cheong Hui, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong · 2020 · Gut
  76. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak
    Andrea Sansone, Daniele Mollaioli, Giacomo Ciocca, Erika Limoncin, Elena Colonnello, Walter Vena, Emmanuele Angelo Jannini · 2020 · Journal of Endocrinological Investigation
  77. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)
    Célestin Danwang, Francky Teddy Endomba, Jan René Nkeck, Dominic Leandry Angong Wouna, Annie R Robert, Jean Jacques Noubiap · 2020 · Biomarker Research
  78. Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition)
    Kunling Shen, Global Pediatric Pulmonology Alliance, Yonghong Yang, Rongmeng Jiang, Tianyou Wang, Dongchi Zhao, Yi Jiang, Xiaoxia Lü, Runming Jin, Yuejie Zheng et al. · 2020 · World Journal of Pediatrics
  79. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
    Florence WJ Chioh, Siew‐Wai Fong, Barnaby Edward Young, Kan Xing Wu, Anthony Siau, Shuba Krishnan, Yi‐Hao Chan, Guillaume Carissimo, Louis LY Teo, Fei Gao et al. · 2021 · eLife
  80. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China
    Xin Li, Zhen Guo, Bailing Li, Xiaolin Zhang, Rui Tian, Wei Wu, Zhongwei Zhang, Yunfei Lu, Nan Chen, Sean Patrick Clifford et al. · 2020 · ASAIO Journal
  81. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study
    Qilin Li, Xiuli Ding, Geqing Xia, Heng‐Gui Chen, Fenghua Chen, Zhi Geng, Luming Xu, Shijun Lei, An Pan, Lin Wang et al. · 2020 · EClinicalMedicine
  82. Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective
    Yashpal Singh Malik, Naveen Kumar, Shubhankar Sircar, Rahul Kaushik, Sudipta Bhat, Kuldeep Dhama, Parakriti Gupta, Kapil Goyal, Mini Pritam Singh, Ujjala Ghoshal et al. · 2020 · Pathogens
  83. COVID‐19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
    Manuel F. Landecho, José Ramón Yuste, Elsa Gándara, Patricia Sunsundegui, Jorge Augusto Quiroga, Ana B. Alcaide, Alfredo García‐Layana · 2020 · Journal of Internal Medicine
  84. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19
    Richard Gentry Wilkerson, Jason D. Adler, Nirav G. Shah, Robert Bruce Brown · 2020 · The American Journal of Emergency Medicine
  85. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19
    Yujiao Zhang, Xiaoyuan Zeng, Yingying Jiao, Zongpeng Li, Qifa Liu, Jieyu Ye, Mo Yang · 2020 · Thrombosis Research
  86. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis
    Catherine Ruth Jutzeler, Lucie Bourguignon, Caroline Weis, Bobo Tong, Cyrus Wong, Bastian Rieck, Hans Pargger, Sarah Tschudin‐Sutter, Adrian Egli, Karsten Michael Borgwardt et al. · 2020 · Travel Medicine and Infectious Disease
  87. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study
    Guohui Fan, Chao Tu, Fei Zhou, Zhibo Liu, Yeming Wang, Bin Song, Xiaoying Gu, Yimin Wang, Yuan Wei, Hui Li et al. · 2020 · European Respiratory Journal
  88. SARS-CoV-2: characteristics and current advances in research
    Yicheng Yang, Zhiqiang Xiao, Kaiyan Ye, Xiaoen He, Bo Sun, Zhiran Qin, Jianghai Yu, Jinxiu Yao, Qinghua Wu, Zhang Bao et al. · 2020 · Virology Journal
  89. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
    Andrew Ip, Donald A. Berry, Eric Hansen, Andre Henri Goy, Andrew L. Pecora, Brittany Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M. Berry, Nicholas Berry et al. · 2020 · PLoS ONE
  90. Immune responses during COVID-19 infection
    Cléa Melenotte, Aymeric Silvin, Anne‐Gaëlle Goubet, Imran Lahmar, Agathe Dubuisson, Alimuddin I. Zumla, Didier Raoult, Mansouria Merad-Boudia, Bertrand Gachot, Clémence Henon et al. · 2020 · OncoImmunology
  91. Cardiac Involvement of COVID-19: A Comprehensive Review
    Wei‐Ting Chang, Han Siong Toh, Chia‐Te Liao, Wen‐Liang Yu · 2020 · The American Journal of the Medical Sciences
  92. Innate and adaptive immune responses against coronavirus
    Arezoo Hosseini, Vida Hashemi, Navid Shomali, Faezeh Asghari, Tohid Gharibi, Morteza Akbari, Saber Gholizadeh, Abbas Jafari · 2020 · Biomedicine & Pharmacotherapy
  93. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
    Ruirong Chen, Zhien Lan, Jujian Ye, Limin Pang, Yi Liu, Wei Wu, Xiaohuan Qin, Yang Guo, Peidong Zhang · 2021 · Frontiers in Immunology
  94. Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19
    Amy Lee Lightner, Vikram Sengupta, Sascha Qian, John T. Ransom, Sam Suzuki, David J. Park, Timothy I. Melson, Brian P. Williams, James J. Walsh, Mustafa Awili · 2023 · CHEST Journal
  95. Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
    Huijie Bian, Zhaohui Zheng, Ding Wei, Zheng Zhang, Wenzhen Kang, Chun-Qiu Hao, Ke Dong, Wen Kang, Jielai Xia, Jinlin Miao et al. · 2020 · medRxiv
  96. Shipping markets in turmoil: An analysis of the Covid-19 outbreak and its implications
    Michail, Nektarios A., Melas, Kostis D. · 2020 · Transportation Research Interdisciplinary Perspectives
  97. Positive Epstein-Barr Virus Detection in Corona Virus Disease 2019 (COVID-19) Patients
    Ting Chen, Jiayi Song, Hongli Liu, Hongmei Zheng, Changzheng Chen · 2020 · Scientific Reports
  98. Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
    Jiansheng Huang, Wenliang Song, Hui Huang, Quancai Sun · 2020 · Journal of Clinical Medicine
  99. Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
    Saeed K Alzghari, Valerie S. Acuña · 2020 · Journal of Clinical Virology
  100. Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
    Ziyun Shao, Yongwen Feng, Li Zhong, Qifeng Xie, Ming Lei, Zheying Liu, Conglin Wang, Jingjing Ji, Huiheng Liu, Zhengtao Gu et al. · 2020 · Clinical & Translational Immunology